Does BENZOYLPAS ANHYDROUS Cause Hypercholesterolaemia? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hypercholesterolaemia have been filed in association with BENZOYLPAS ANHYDROUS. This represents 47.2% of all adverse event reports for BENZOYLPAS ANHYDROUS.
25
Reports of Hypercholesterolaemia with BENZOYLPAS ANHYDROUS
47.2%
of all BENZOYLPAS ANHYDROUS reports
25
Deaths
7
Hospitalizations
How Dangerous Is Hypercholesterolaemia From BENZOYLPAS ANHYDROUS?
Of the 25 reports, 25 (100.0%) resulted in death, 7 (28.0%) required hospitalization, and 7 (28.0%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENZOYLPAS ANHYDROUS. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does BENZOYLPAS ANHYDROUS Cause?
Prescribed underdose (31)
Osteoporosis (30)
Pneumonia (30)
Visual impairment (30)
Joint dislocation (28)
Joint stiffness (28)
Musculoskeletal stiffness (28)
Nasopharyngitis (28)
Nausea (28)
Oedema (28)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)